Global Pharmaceutical Manufacturing Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2029
“Global Pharmaceutical Manufacturing Market” is the title of an upcoming report offered by MarketResearch.Biz. The report contains information and data, and inputs from both primary and secondary data sources, that have been verified and validated by experts in the target market. The report presents a thorough study of revenues, historical data, and information, key developments, and strategies by major players that offer vital insights and perspectives in to various scenarios market. Besides critical data and related information, the report includes key trends (both present and future), factors that are driving market growth, factors that are or could be potential restraints to market growth, as well as opportunities that can be leveraged for potential revenue generation in untapped regions and countries. It also covers threats or challenges for existing as well as new entrants in the market. The global pharmaceutical manufacturing market has been segmented on the basis of drug development type, formulation, route of administration, therapy area, prescription, age group, distribution channel, as well as regions and countries.
Pharmaceutical manufacturing, also referred to as drug manufacturing, is the process of industrial-scale synthesis of pharmaceutical drugs as part of the pharmaceutical industry. The process of drug manufacturing cam be broken down into a series of unit operations, such as milling, granulation, coating, tablet, pressing, and others.
The increasing amount of investments being made by key industry players towards the expansion of manufacturing facilities across the world owing to the increasing demands for pharmaceutical products is a major factor that is expected to have a profound impact on the revenue growth of the global pharmaceutical manufacturing market over the next 10 years.
Moreover, the incorporation of various technological advancements that allow for improved and error-free manufacturing operational capabilities, as well as the numerous developments in the field of personalized medicine, are also factors that are slated to have a significant influence on the future market growth of this global industry.
However, in light of the recent COVID-19 outbreak, the operations of numerous industries have been either temporarily halted or are functioning with a minimal workforce due to enforced lockdowns and imposed restrictions by respective governing bodies. The global pharmaceutical manufacturing industry is no different, and this factor is expected to negatively impact on market growth in the years to come. Nevertheless, due to the expected surge in the demand for appropriate medicinal supplies, as a result of the pandemic, is also a factor that is slated to soften the blow dealt to this industry in the near future.
Furthermore, the growing number of drug approvals by respective regulatory bodies is another factor that is anticipated to augment industry growth for the global pharmaceutical manufacturing market in the coming years.
Segmentation of the global pharmaceutical manufacturing market is as follows:
In terms of drug development type, the in-house segment accounted for the maximum number of revenue shares of the global pharmaceutical manufacturing market in 2020, and is slated to register a considerable rate of revenue growth in the coming years. This can be accredited to the fact that a majority of this industry’s players prefer to keep their manufacturing operations in this manner as a means to ensure product confidentiality.
On the basis of formulation, the tablet segment constituted the majority number of revenue shares of the global pharmaceutical manufacturing market in 2020, due to the wide availability of these products. However, the injectable segment is slated to index the highest CAGR over the forecast period, owing to the increase in the approvals and availability of pre-filled syringes and auto-injectors.
With regards to the route of administration, the oral segment accounted for the maximum number of revenue shares of the global pharmaceutical manufacturing market in 2020, as oral forms are easy-to-manufacture, affordable, and patent-friendly.
Based on therapy area, the other diseases segment accounted for the most number of revenue shares of the global pharmaceutical manufacturing market in 2020, whereas, the cancer segment accounted for the second-most number of revenue shares.
In terms of prescription market outlook, the prescription medicines segment accounted for the highest number of revenue shares of this global market in 2020, and is indicative of doing so over the next 10 years.
On the basis of age group, the geriatric segment accounted for the majority number of revenue shares of the global pharmaceutical manufacturing market in 2020, and is expected to continue doing so over the forecast period.
With respect to distribution channel, the retail segment accounted for the highest number of revenue shares of this global market in 2020, and are gradually gaining more prominence due to the growing availability of specialty drugs present in them.
Regional Segmentation and Analysis:
North America accounted for the highest number of revenue shares of the global pharmaceutical manufacturing market in 2020. This can be attributed to a greater number of key industry players in the region, as well as the presence of a well-established healthcare system. However, the markets in the Asia Pacific are anticipated to register the highest CAGR over the next 10 years, owing to factors such as the presence of a large consumer base, increasing healthcare expenditures, as well as the rising incidence of diseases in this region.
Segmentation of the Global Pharmaceutical Manufacturing Market:
Segmentation by Drug Development Type:
Segmentation by Formulation:
- Other Formulations
Segmentation by Route of Administration:
- Other Routes of Administration
Segmentation by Therapy Area:
- Cardiovascular Diseases
- Respiratory Diseases
- Other Diseases
Segmentation by Prescription:
- Prescription Medicines
- Over-the-counter (OTC) Medicines
Segmentation by Age Group:
- Children & Adolescents
Segmentation by Distribution Channel:
Segmentation by Regions:
- North America
- South America
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Actual Year 2020 Estimated Year 2021 Forecast Period 2021–2030 Revenue in US$
- Hoffmann-La Roche Ltd.
- Novartis AG
- GlaxoSmithKline plc
- Pfizer Inc.
- AstraZeneca Plc
- Merck & Co. Inc.
- Johnson & Johnson
- Sanofi SA
- Eli Lilly and Company
- Lonza Group
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!